Dendritic cell vaccines for high-grade gliomas
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-07-26 / Ther Clin Risk Manag 2018;14:1299-1313A novel allogeneic off-the-shelf dendritic cell vaccine for post-remission treatment of elderly patients with acute myeloid leukemia
/in Acute Leukemia, Dendritic Cells, International Publications /von 2018-07-23 / Cancer Immunol. Immunother. 2018 Oct;67(10):1505-1518Targeting dendritic cells in pancreatic ductal adenocarcinoma
/in Dendritic Cells, Exosome, International Publications, Pancreatic Cancer /von 2018-06-18 / Cancer Cell Int. 2018;18:85Interim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2018-06-04 / J Clin Oncol 36, 2018 (suppl; abstr 9525)Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with epithelial ovarian carcinoma (EOC) after primary debulking surgery (PDS): Interim analysis of a phase 2, open-label, randomized, multicenter trial.
/in Dendritic Cells, International Publications /von 2018-06-03 / J Clin Oncol 36, 2018 (suppl; abstr 5509)Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial.
/in Dendritic Cells, NSCLC /von 2018-06-03 / J Clin Oncol 36, 2018 (suppl; abstr 9051)Dendritic cell vaccine (DCVAC) with chemotherapy (ct) in patients (pts) with recurrent epithelial ovarian carcinoma (EOC) after complete response (CR) to 1st-line platinum (Pt)-based ct: Primary analysis of a phase 2, open-label, randomized, multicenter trial.
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2018-06-01 / J Clin Oncol 36, 2018 (suppl; abstr e17515)Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses
/in Dendritic Cells, Hypernephroma, International Publications, Urothelial Carcinoma /von 2018-05-30 / Ther Apher Dial 2018 Jun;22(3):266-277First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
/in Dendritic Cells, Glioblastoma, International Publications /von 2018-05-29 / J Transl Med 2018 May;16(1):142
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de